Stephen Bloch
InvestorFounderGeneral Partner at Canaan Partners · Special Advisor at JSD Capital, LLC · Board director at Liquidia Corporation · Board director at Iantrek · Board director at Genome Medical Holding Co
Westport, Connecticut
Writes $250K – $20M checks · typically $10M
About
Stephen Bloch is a former physician and 20+ year healthcare investor across biopharma, medtech, and digital health who combines General Partner experience with running EvolveImmune Therapeutics as an active operator-investor.
Invests in
BiotechConsumerDeep TechDigital HealthEnterprise SoftwareFintechHardwareHealthtechMedical Devices
Board director at Liquidia Corporation
Intro paths
In turn, Stephen can intro founders to Liquidia Corporation's investors below.
Board director at Iantrek
Intro paths
In turn, Stephen can intro founders to Iantrek's investors below.
Iantrek's investors · 7
Co-founders at Iantrek
Board director at Genome Medical Holding Co
Intro paths
In turn, Stephen can intro founders to Genome Medical Holding Co's investors below.
Genome Medical Holding Co's investors · 3
Co-founders at Genome Medical Holding Co
Experience
- BiotechnologyChief Executive Officercurrent2019 — presentNew Haven County, Connecticut, United States
- EvolveImmune TherapeuticsChief Executive Officercurrent2019 — presentNew Haven, CT
- Allyx Therapeutics, Inc.Chief Executive Officercurrent2019 — presentNew Haven, CT
- Canaan PartnersGeneral Partnercurrent2002 — presentWestport, CT
- Liquidia CorporationChairman Of The Boardcurrent2018 — present
- Radiology Management SciencesChief Executive Officer1995 — 2002Cambridge, MA
- Arthur D. Littleconsultant1994 — 1995
Education
- Massachusetts General HospitalDiagnostic Radiology Residency and Fellowship1990 — 1994
- Dartmouth CollegeAB, History1980 — 1984
- University of Rochester School of Medicine and DentistryDoctor of Medicine (MD), Medicine1984 — 1989
- Harvard UniversityMaster of Arts (MA), History and Philosophy of Science and Technology1987 — 1988
- Lenox Hill HospitalInternal Medicine Residency Program1989 — 1990
Skills & more
+1 more
StrategyFrom Stephen's professional profile.
Deals · 7
Liquidia CorporationBoard seat
via Canaan Partners · filed Apr 2021 · $21.7M raise
IantrekBoard seat
via Canaan Partners · filed Oct 2020 · $5.2M raise
Liquidia TechnologiesBoard seat
via Canaan Partners · filed Jan 2020 · $22.4M raise
Genome Medical Holding CoBoard seat
via Canaan Partners · filed Aug 2018 · $223.2K raise
Dicom GridBoard seat
via Canaan Partners · filed Nov 2017 · $7.4M raise
TruverisBoard seat
via Canaan Partners · filed Aug 2017 · $34.7M raise
Envisia TherapeuticsBoard seat
via Canaan Partners · filed Oct 2015 · $5.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Investor
Advanced BioHealingAmbra HealthAmicus TherapeuticsEnvisiaMarinus Pharmaceuticals
Sources: SEC Form D filings · the firm's website.
Colleagues at Canaan Partners
%20copy.jpg)
Network1
Investors connected to Stephen in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Stephen Bloch?
- Stephen Bloch is a former physician and 20+ year healthcare investor across biopharma, medtech, and digital health who combines General Partner experience with running EvolveImmune Therapeutics as an active operator-investor.
- Where does Stephen Bloch work?
- Stephen Bloch is General Partner at Canaan Partners and Board director at Liquidia Corporation and Board director at Iantrek and Board director at Genome Medical Holding Co.
- What does Stephen Bloch invest in?
- Stephen Bloch invests in Biotech, Consumer, Deep Tech, Digital Health, Enterprise Software, Fintech, Hardware, Healthtech, Medical Devices.
- What check size does Stephen Bloch write?
- Stephen Bloch typically writes checks of $250K – $20M.
- What boards does Stephen Bloch sit on?
- Stephen Bloch holds tracked board seats at Dicom Grid, Envisia Therapeutics, Genome Medical Holding Co, Iantrek, Liquidia Corporation, Liquidia Technologies, Onkos Surgical, Truveris.
- What companies has Stephen Bloch invested in?
- Investments tracked here include Advanced BioHealing, Ambra Health, Amicus Therapeutics, Envisia, Liquidia Corporation, Marinus Pharmaceuticals.
- Where did Stephen Bloch go to school?
- Stephen Bloch studied at Massachusetts General Hospital (Diagnostic Radiology Residency and Fellowship); Dartmouth College (AB, History); University of Rochester School of Medicine and Dentistry (Doctor of Medicine (MD), Medicine).
Founder mafias
Dartmouth College mafia90
Also came through, then founded or led a company.
+ 83 more
Canaan Partners mafia3
Also came through, then founded or led a company.
Iantrek mafia2
Also came through, then founded or led a company.
Liquidia Technologies mafia2
Also came through, then founded or led a company.
Truveris mafia2
Also came through, then founded or led a company.
Same school
Also attended Dartmouth College400
+ 394 more
Also attended University of Rochester School of Medicine and Dentistry4
Also attended Harvard University1,483
+ 1,477 more
Shared employers
Also worked at EvolveImmune Therapeutics2
Also worked at Liquidia Corporation3
Also worked at Arthur D. Little48
+ 42 more